CARE Ratings Q2 FY25 earnings call: Revenue & Margins
Q2 FY25 investor presentation: what the company reported on revenue, margins and capex.
- Revenue
- ₹117Cr
- +21.9% YoY
- +48.1% QoQ
- Net profit
- ₹47Cr
- +30.6% YoY
- +123.8% QoQ
- Margin
- 47%
- +4 pp YoY
- +19 pp QoQ
Guidance rank: #20 of 27 in Capital Markets
See the sector's top 10 — free with your mobile number.
CARE Ratings Ltd Q2 FY25 key numbers
- Revenue
- Consolidated Revenue from Operations Q2 FY25: Rs. 196.29 Crs, up 21% YoY.
As stated in CARE Ratings Ltd's Q2 FY25 investor presentation · published 25 Sept 2026. Reported figures, not investment advice.
Based on CARE Ratings Ltd's Q2 FY25 investor presentation. The company has not published an earnings-call transcript for this quarter, so figures here are what the investor presentation reports, not management guidance.
The short version
Consolidated Revenue from Operations Q2 FY25: Rs. 196.29 Crs, up 21% YoY (Page 13, 2, 12). Standalone Q2 FY25:.
From CARE Ratings Ltd's Q2 FY25 earnings-call transcript · updated 25 Sept 2026.
Revenue & Sales Performance
- Consolidated Revenue from Operations Q2 FY25: Rs. 196.29 Crs, up 21% YoY (Page 13, 2, 12)
- Standalone Revenue from Operations Q2 FY25: Rs. 166.85 Crs, up 18% YoY (Page 12, 2)
- Ratings Business Revenue YoY growth: 19%, Rs. 177.63 Crs for H1FY25 (Page 14, 2)
- Non-Ratings Business Revenue YoY growth: 37%, Rs. 18.66 Crs for H1FY25 (Page 14, 2)
2 more points from CARE Ratings Ltd's call on revenue
Create a free account to keep reading this call
Profitability & Margins
Standalone Q2 FY25:
Locked: what CARE Ratings Ltd said on margins
Also locked on this page: capex, fundraising, order book
Free account, 30 seconds. No card needed.
Capital Expenditure Plans
See what CARE Ratings Ltd said on capital expenditure plans — free account, 30 seconds.
Top-ranked in Capital Markets
Ranked on what management guided this quarter
Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Fundraising & Capital Structure
Key relevant points include:
Locked: what CARE Ratings Ltd said on fundraising
Also locked on this page: margins, capex, order book
Free account, 30 seconds. No card needed.
Order Book & Pipeline
See what CARE Ratings Ltd said on order book & pipeline — free account, 30 seconds.
CARE Ratings Ltd — Quarterly revenue & net profit
CARE Ratings Ltd Q2 FY25 results — key figures
| ₹ Cr | Q2 FY25 | Q2 FY24 | YoY | Q1 FY25 | QoQ |
|---|---|---|---|---|---|
| Revenue | 117 | 96 | +21.9% | 79 | +48.1% |
| Operating profit (EBITDA) | 56 | 42 | +33.3% | 22 | +154.5% |
| Operating margin | 47% | 43% | +4 pp | 28% | +19 pp |
| Profit before tax | 64 | 50 | +28% | 30 | +113.3% |
| Net profit (PAT) | 47 | 36 | +30.6% | 21 | +123.8% |
| EPS (₹) | 15.41 | 11.81 | +30.5% | 6.94 | +122% |
Source: reported quarterly figures (Screener), ₹ crore.
Reported quarterly figures (₹ Cr). Latest (Q2 FY27): revenue ₹164 Cr, net profit ₹72 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.
Full financials →Continue your research
What CARE Ratings's management said in earlier quarters
Others in Capital Markets this season
- IIFL Capital (Q2 FY25)
Revenue for Q2 FY25: ₹7,037 million, up 32% YoY from ₹5,337 million in Q2 FY24 (Page 20) . Key concall takeaways from IIFL Capital Services Ltd's Q2 FY25…
- Geojit Financial Services (Q2 FY25)
Market Capitalization as on 30th September 2024: ₹3,690 crore . Key concall takeaways from Geojit Financial Services Ltd's Q2 FY25 earnings call — and how it…
Potential multibaggers · Q2 FY27
Potential multibaggers in Capital Markets
on management's own guidance
- Motilal Oswal Financial ServicesGood growth2
- BSEGood growth1
- Anand Rathi WealthGood growth3
Portfolio builder
Build your portfolio
from the top-ranked stocks
- 1. Pick 3–15 stocks
- 2. Choose large, mid or small cap and your sectors
- 3. Get a portfolio built from the rankings
Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.
Arthneeti Pro · Annual
CARE Ratings Ltd and 15K+ more earnings calls,
for less than your morning chai
Every earnings call, ranking and concall Q&A across all four results seasons.
Secure Razorpay payment · instant access
Frequently Asked Questions
What were CARE Ratings Ltd Q2 FY25 results?
Consolidated Revenue from Operations Q2 FY25: Rs. 196.29 Crs, up 21% YoY (Page 13, 2, 12). Standalone Q2 FY25:.
What is CARE Ratings Ltd share price analysis?
CARE Ratings Ltd currently shows a neutral. The stock trades at a P/E of 28.3 with a market cap of ₹5,026 Cr. Investors should review the full earnings analysis for detailed insights.
Keep CARE Ratings Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and the company's investor presentation. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.